Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma
Status:
Terminated
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of escalating doses of SD-101 in combination with
localized low-dose radiation therapy in adult subjects with untreated low-grade B-cell
lymphoma.